Serentis Starts Phase II Trial with First-in-Class SRD441 for Eczema
4/7/2009 10:17:03 AM
More...
|
Serentis Starts Phase II Clinical Trial in Pruritus of Skin Disease
3/4/2009 10:19:41 AM
More...
|
Serentis Expands Series A Financing
8/12/2008 8:08:54 AM
More...
|
Serentis Appoints Peter Keen as New Corporate Development and Finance Director
10/30/2007 9:14:54 AM
More...
|
Serentis Acquires Atopic Dermatitis Company Surface Therapeutics
10/2/2007 8:54:33 AM
More...
|
Serentis Raises £10.3 Million Series A Financing
7/3/2007 10:04:05 AM
More...
|